{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:10:12Z","timestamp":1793149812841,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>\n            <jats:italic>Candida auris<\/jats:italic> is an emerging multidrug-resistant yeast that causes healthcare-associated and deep-seated infections. Notably, the emergence of this yeast is alarming as it exhibits resistance to azoles, echinocandins, and amphotericin B, which may lead to clinical treatment failure in patients. This study aims to identify and characterize the genetic determinants of antifungal resistance in <jats:italic>C. auris<\/jats:italic> among some local clinical isolates to contribute for understanding the molecular epidemiology of <jats:italic>C. auris<\/jats:italic> in Egypt. Four test strains were identified based on the ribosomal internal transcribed spacer (ITS) region sequence and phylogenetic analysis. Antifungal susceptibility was determined using the VITEK 2 system. Molecular analysis of <jats:italic>ERG11<\/jats:italic>,<jats:italic> ERG3<\/jats:italic>,<jats:italic> FKS1<\/jats:italic>, and <jats:italic>FKS2<\/jats:italic> was used to identify mutations associated with antifungal resistance. The four test strains were identified as <jats:italic>C. auris<\/jats:italic>. Evolutionary analysis was conducted, and sequences of ITS regions were submitted to GenBank. The mutations Y132F in <jats:italic>ERG11<\/jats:italic> and F635Y in <jats:italic>FKS2<\/jats:italic> were identified, which are known to confer resistance to azoles and echinocandins, respectively. The emergence of <jats:italic>C. auris<\/jats:italic> in Egypt represents a public health concern. Hospitals should implement strict infection control measures to prevent its spread. Effective treatment guidelines and ongoing monitoring of antifungal resistance are essential to combat this emerging pathogen.<\/jats:p>","DOI":"10.1038\/s41598-025-88656-3","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:35:31Z","timestamp":1739176531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Molecular characterization of some multidrug resistant Candida Auris in egypt"],"prefix":"10.1038","volume":"15","author":[{"given":"Sara H.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman M. A.","family":"El-Kholy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel A.","family":"El-Mehalawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia A.","family":"Elkady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"issue":"7","key":"88656_CR1","doi-asserted-by":"publisher","first-page":"e00053","DOI":"10.1128\/aac.00053-22","volume":"66","author":"SE -Jacobs","year":"2022","unstructured":"-Jacobs, S. E. et al. Candida Auris pan-drug-resistant to four classes of antifungal agents. Antimicrob. Agents Chemother. 66(7), e00053\u2013e00022. https:\/\/doi.org\/10.1128\/aac.00053-22 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"88656_CR2","unstructured":"-Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. US Department of Health and Human Services, Centres for Disease Control and Prevention; 2019. (2019). https:\/\/www.cdc.gov\/drugresistance\/biggest-threats.html. (accessed on August 5, 2024)."},{"key":"88656_CR3","doi-asserted-by":"crossref","unstructured":"-Preda, M., Chivu, R. D., Ditu, L. M., Popescu, O. & Manolescu, L. S. Pathogenesis, Prophylaxis, and Treatment of Candida auris. Biomedicines. ;12(3):561.\/biomedicines12030561 World Health Organization. WHO fungal priority pathogens list to guide research, development, and public health action. World Health Organization; 2022 Oct 25. (2024). https:\/\/www.who.int\/publications\/i\/item\/9789240060241 (accessed on August 16, 2024).","DOI":"10.3390\/biomedicines12030561"},{"key":"88656_CR4","unstructured":"World Health Organization. WHO fungal priority pathogens list to guide research, development, and public health action. World Health Organization. https:\/\/www.who.int\/publications\/i\/item\/9789240060241. (accessed on August 16, 2024)."},{"issue":"4","key":"88656_CR5","doi-asserted-by":"publisher","first-page":"e00842","DOI":"10.1128\/mbio.00842-22","volume":"13","author":"LS -Burrack","year":"2022","unstructured":"-Burrack, L. S., Todd, R. T., Soisangwan, N., Wiederhold, N. P. & Selmecki, A. Genomic diversity across Candida Auris clinical isolates shapes rapid development of antifungal resistance in vitro and in vivo. MBio 13(4), e00842\u2013e00822. https:\/\/doi.org\/10.1128\/mbio.00842-22 (2022).","journal-title":"MBio"},{"issue":"1","key":"88656_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/myc.13022","volume":"63","author":"S -Ahmad","year":"2020","unstructured":"-Ahmad, S., Khan, Z., Al-Sweih, N., Alfouzan, W. & Joseph, L. Candida Auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs. Mycoses 63(1), 104\u2013112 (2020).","journal-title":"Mycoses"},{"key":"88656_CR7","doi-asserted-by":"publisher","unstructured":"-Ademe, M. & Girma, F. Candida Auris: from multidrug resistance to pan-resistant strains. Infection and drug resistance. May 5, 1287\u20131294. (2020). https:\/\/doi.org\/10.2147\/IDR.S249864","DOI":"10.2147\/IDR.S249864"},{"key":"88656_CR8","unstructured":"-Suphavilai, C. et al. et. al. Detection and characterization of a sixth Candida Auris clade in Singapore: a genomic and phenotypic study. Lancet Microbe ;5(9). (2024)."},{"issue":"9","key":"88656_CR9","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/antibiotics9090568","volume":"9","author":"MG -Fr\u00edas-De-Le\u00f3n","year":"2020","unstructured":"-Fr\u00edas-De-Le\u00f3n, M. G. et al. Antifungal resistance in Candida Auris: molecular determinants. Antibiotics 9(9), 568. https:\/\/doi.org\/10.3390\/antibiotics9090568 (2020).","journal-title":"Antibiotics"},{"issue":"18","key":"88656_CR10","doi-asserted-by":"publisher","first-page":"19816","DOI":"10.1021\/acsomega.3c08134","volume":"9","author":"H -Izumi","year":"2024","unstructured":"-Izumi, H., Nafie, L. A. & Dukor, R. K. Effect of conformational variability on the Drug Resistance of Candida Auris ERG11p and FKS1. ACS Omega. 9(18), 19816\u201319823 (2024).","journal-title":"ACS Omega"},{"issue":"1","key":"88656_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1146\/annurev-micro-032521-015858","volume":"77","author":"A -Chowdhary","year":"2023","unstructured":"-Chowdhary, A., Jain, K. & Chauhan, N. Candida Auris genetics and emergence. Annu. Rev. Microbiol. 77(1), 583\u2013602. https:\/\/doi.org\/10.1146\/annurev-micro-032521-015858 (2023).","journal-title":"Annu. Rev. Microbiol."},{"key":"88656_CR12","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.3389\/fmicb.2019.02788","volume":"10","author":"F -Chaabane","year":"2019","unstructured":"-Chaabane, F., Graf, A., Jequier, L. & Coste, A. T. Review on antifungal resistance mechanisms in the emerging pathogen Candida Auris. Front. Microbiol. 10, 2788. https:\/\/doi.org\/10.3389\/fmicb.2019.02788 (2019).","journal-title":"Front. Microbiol."},{"issue":"2","key":"88656_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.03333-20","volume":"12","author":"H -Carolus","year":"2021","unstructured":"-Carolus, H. et al. Genome-wide analysis of experimentally evolved Candida Auris reveals multiple novel mechanisms of multidrug resistance. MBio 12(2), 10\u2013128. https:\/\/doi.org\/10.1128\/mBio.03333-20 (2021).","journal-title":"MBio"},{"key":"88656_CR14","doi-asserted-by":"publisher","first-page":"102208","DOI":"10.1016\/j.mib.2022.102208","volume":"70","author":"JM -Rybak","year":"2022","unstructured":"-Rybak, J. M., Cuomo, C. A. & Rogers, P. D. The molecular and genetic basis of antifungal resistance in the emerging fungal pathogen Candida Auris. Curr. Opin. Microbiol. 70, 102208. https:\/\/doi.org\/10.1016\/j.mib.2022.102208 (2022).","journal-title":"Curr. Opin. Microbiol."},{"issue":"1","key":"88656_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/jof7010018","volume":"7","author":"R -AlJindan","year":"2020","unstructured":"-AlJindan, R. et al. Drug resistance-associated mutations in erg11 of multidrug-resistant Candida Auris in a tertiary care hospital of eastern Saudi Arabia. J. Fungi. 7(1), 18. https:\/\/doi.org\/10.3390\/jof7010018 (2020).","journal-title":"J. Fungi"},{"issue":"3","key":"88656_CR16","doi-asserted-by":"publisher","first-page":"e01585","DOI":"10.1128\/Spectrum.01585-21","volume":"9","author":"JM -Rybak","year":"2021","unstructured":"-Rybak, J. M. et al. Delineation of the direct contribution of Candida Auris ERG11 mutations to clinical triazole resistance. Microbiol. Spectr. 9(3), e01585\u2013e01521. https:\/\/doi.org\/10.1128\/Spectrum.01585-21 (2021).","journal-title":"Microbiol. Spectr."},{"key":"88656_CR17","unstructured":"-Centers for Disease Control and Prevention. Identification of Candida auris October (2024). https:\/\/www.cdc.gov\/candida-auris\/hcp\/laboratories\/identification-of-c-auris.html. Accessed 1st."},{"key":"88656_CR18","volume-title":"Ostrosky-Zeichner L. M27-A3 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts","author":"JH -Rex","year":"2008","unstructured":"-Rex, J. H. et al. Ostrosky-Zeichner L. M27-A3 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts (Approved Standard, 2008)."},{"issue":"4","key":"88656_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/jgid.jgid_44_22","volume":"14","author":"S -Deshkar","year":"2022","unstructured":"-Deshkar, S. et al. Identification and antifungal drug susceptibility pattern of Candida Auris in India. J. Global Infect. Dis. 14(4), 131\u2013135 (2022).","journal-title":"J. Global Infect. Dis."},{"key":"88656_CR20","doi-asserted-by":"publisher","first-page":"204993612311613","DOI":"10.1177\/20499361231161387","volume":"10","author":"LS -Sigera","year":"2023","unstructured":"-Sigera, L. S. & Denning, D. W. Flucytosine and its clinical usage. Therapeutic Adv. Infect. Disease. 10, 20499361231161387 (2023).","journal-title":"Therapeutic Adv. Infect. Disease"},{"issue":"8","key":"88656_CR21","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1128\/JCM.40.8.2860-2865.2002","volume":"40","author":"G -Luo","year":"2002","unstructured":"-Luo, G. & Mitchell, T. G. Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J. Clin. Microbiol. 40(8), 2860\u20132865 (2002).","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"88656_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF -Altschul","year":"1990","unstructured":"-Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215(3), 403\u2013410 (1990).","journal-title":"J. Mol. Biol."},{"issue":"12","key":"88656_CR23","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/molbev\/mst197","volume":"30","author":"K -Tamura","year":"2013","unstructured":"-Tamura, K., Stecher, G., Peterson, D., Filipski, A. & Kumar, S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 30(12), 2725\u20132729 (2013).","journal-title":"Mol. Biol. Evol."},{"issue":"1","key":"88656_CR24","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1080\/21505594.2021.1927609","volume":"12","author":"V -Lara-Aguilar","year":"2021","unstructured":"-Lara-Aguilar, V. et al. Adaptation of the emerging pathogenic yeast Candida Auris to high caspofungin concentrations correlates with cell wall changes. Virulence 12(1), 1400\u20131417. (2021).","journal-title":"Virulence"},{"issue":"5","key":"88656_CR25","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/microorganisms12050927","volume":"12","author":"S -De Gaetano","year":"2024","unstructured":"-De Gaetano, S., Midiri, A., Mancuso, G., Avola, M. G. & Biondo, C. Candida Auris outbreaks: current status and future perspectives. Microorganisms 12(5), 927. https:\/\/doi.org\/10.3390\/microorganisms12050927 (2024).","journal-title":"Microorganisms"},{"key":"88656_CR26","volume-title":"Candida auris.[Updated 2023 Aug 28]. StatPearls [Internet]","author":"A -Sikora","year":"2024","unstructured":"-Sikora, A., Hashmi, M. F. & Zahra, F. Candida Auris.[Updated 2023 Aug 28]. StatPearls [Internet] (StatPearls Publishing, 2024)."},{"issue":"1","key":"88656_CR27","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1038\/s41467-018-07779-6","volume":"9","author":"JF -Mu\u00f1oz","year":"2018","unstructured":"-Mu\u00f1oz, J. F. et al. Genomic insights into multidrug resistance, mating and virulence in Candida Auris and related emerging species. Nat. Commun. 9(1), 5346. https:\/\/doi.org\/10.1038\/s41467-018-07779-6 (2018).","journal-title":"Nat. Commun."},{"issue":"1","key":"88656_CR28","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/s41598-020-58203-3","volume":"10","author":"S -Shaban","year":"2020","unstructured":"-Shaban, S., Patel, M. & Ahmad, A. Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida Auris. Sci. Rep. 10(1), 1162 (2020).","journal-title":"Sci. Rep."},{"issue":"6","key":"88656_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.00485-17","volume":"61","author":"MC -Arendrup","year":"2017","unstructured":"-Arendrup, M. C., Prakash, A., Meletiadis, J., Sharma, C. & Chowdhary, A. Comparison of EUCAST and CLSI reference microdilution MICs of eight antifungal compounds for Candida Auris and associated tentative epidemiological cutoff values. Antimicrob. Agents Chemother. 61(6), 10\u2013128 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"22","key":"88656_CR30","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3390\/cells12222655","volume":"12","author":"KM -Czajka","year":"2023","unstructured":"-Czajka, K. M. et al. Et. Al. Molecular mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species. Cells 12(22), 2655. https:\/\/doi.org\/10.3390\/cells12222655 (2023).","journal-title":"Cells"},{"issue":"7","key":"88656_CR31","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","volume":"25","author":"KE -Pristov","year":"2019","unstructured":"-Pristov, K. E. & Ghannoum, M. A. Resistance of Candida to azoles and echinocandins worldwide. Clin. Microbiol. Infect. 25(7), 792\u2013798. https:\/\/doi.org\/10.1016\/j.cmi.2019.03.028 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"88656_CR32","doi-asserted-by":"publisher","first-page":"100076","DOI":"10.1016\/j.tcsw.2022.100076","volume":"8","author":"G -Shahi","year":"2022","unstructured":"-Shahi, G. et al. Et. Al. Fluconazole-resistant Candida auris clinical isolates have increased levels of cell wall chitin and increased susceptibility to a glucosamine-6-phosphate synthase inhibitor. Cell. Surf. 8, 100076 (2022).","journal-title":"Cell. Surf."},{"issue":"3","key":"88656_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.00365-20","volume":"11","author":"JM -Rybak","year":"2020","unstructured":"-Rybak, J. M. et al. Et. Al. Mutations in TAC1B: a novel genetic determinant of clinical fluconazole resistance in Candida Auris. MBio 11(3), 10\u2013128. https:\/\/doi.org\/10.1128\/mBio.00365-20 (2020).","journal-title":"MBio"},{"key":"88656_CR34","unstructured":"-Chheda, P. et al. Genetic analysis of drug resistance mechanisms and phylogenetic clustering in Candida Auris isolates from Western India. J. Lab. Physicians 1\u20137 ."},{"issue":"1","key":"88656_CR35","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/jof10010086","volume":"10","author":"Y -Wang","year":"2024","unstructured":"-Wang, Y. & Xu, J. Associations between genomic variants and antifungal susceptibilities in the archived global Candida Auris population. J. Fungi. 10(1), 86. https:\/\/doi.org\/10.3390\/jof10010086 (2024).","journal-title":"J. Fungi"},{"key":"88656_CR36","doi-asserted-by":"crossref","unstructured":"-Chow, N. A. et al. Tracing the evolutionary history and global expansion of Candida Auris using population genomic analyses. mBio 11, e03364\u2013e03319 .","DOI":"10.1128\/mBio.03364-19"},{"issue":"1","key":"88656_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/aac.03470-14","volume":"59","author":"SA -Flowers","year":"2015","unstructured":"-Flowers, S. A., Col\u00f3n, B., Whaley, S. G., Schuler, M. A. & Rogers, P. D. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans. Antimicrob. Agents Chemother. 59(1), 450\u2013460. https:\/\/doi.org\/10.1128\/aac.03470-14 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"88656_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1470-9465.2004.00841.x","volume":"10","author":"JA -Maertens","year":"2004","unstructured":"-Maertens, J. A. History of the development of azole derivatives. Clin. Microbiol. Infect. 10, 1\u20130. (2004).","journal-title":"Clin. Microbiol. Infect."},{"issue":"3","key":"88656_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1130-1406(07)70047-5","volume":"24","author":"JR -Azanza","year":"2007","unstructured":"-Azanza, J. R., Garc\u00eda-Quetglas, E. & S\u00e1daba, B. Farmacolog\u00eda De Los azoles. Revista Iberoamericana De Micolog\u00eda. 24(3), 223\u2013227 (2007).","journal-title":"Revista Iberoamericana De Micolog\u00eda"},{"key":"88656_CR40","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00277-013-1693-5","volume":"92","author":"B -Ping","year":"2013","unstructured":"-Ping, B., Zhu, Y., Gao, Y., Yue, C. & Wu, B. Second-versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis. Ann. Hematol. 92, 831\u2013839. https:\/\/doi.org\/10.1007\/s00277-013-1693-5 (2013).","journal-title":"Ann. Hematol."},{"key":"88656_CR41","doi-asserted-by":"publisher","first-page":"864286","DOI":"10.3389\/fmolb.2022.864286","volume":"9","author":"MM -Matin","year":"2022","unstructured":"-Matin, M. M. et al. Et. Al. Triazoles and their derivatives: Chemistry, synthesis, and therapeutic applications. Front. Mol. Biosci. 9, 864286. https:\/\/doi.org\/10.3389\/fmolb.2022.864286 (2022).","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"88656_CR42","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","volume":"37","author":"M -Szyma\u0144ski","year":"2022","unstructured":"-Szyma\u0144ski, M., Chmielewska, S., Czy\u017cewska, U., Malinowska, M. & Tylicki, A. Echinocandins\u2013structure, mechanism of action and use in antifungal therapy. J. Enzyme Inhib. Med. Chem. 37(1), 876\u2013894. https:\/\/doi.org\/10.1080\/14756366.2022.2050224 (2022).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"88656_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40588-024-00233-w","volume":"22","author":"A -Fenton","year":"2024","unstructured":"-Fenton, A. & John, G. K. Candida Auris Resistance mechanisms to Amphotericin B Alternative Treatments Development. Current clinical Microbiology reports. Jul 22, 1\u20131. https:\/\/doi.org\/10.1007\/s40588-024-00233-w (2024).","journal-title":"Jul"},{"issue":"suppl_6","key":"88656_CR44","doi-asserted-by":"publisher","first-page":"S612","DOI":"10.1093\/cid\/civ791","volume":"61","author":"DS -Perlin","year":"2015","unstructured":"-Perlin, D. S. Echinocandin resistance in Candida. Clin. Infect. Dis. 61(suppl_6), S612\u2013S617. https:\/\/doi.org\/10.1093\/cid\/civ791 (2015).","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"88656_CR45","doi-asserted-by":"publisher","first-page":"e00423","DOI":"10.1128\/aac.00423-23","volume":"67","author":"M -Kordalewska","year":"2023","unstructured":"-Kordalewska, M. et al. Novel non-hot spot modification in Fks1 of Candida Auris confers echinocandin resistance. Antimicrob. Agents Chemother. 67(6), e00423\u2013e00423. https:\/\/doi.org\/10.1128\/aac.00423-23 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"88656_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s44259-023-00007-2","volume":"1","author":"Y -Lee","year":"2023","unstructured":"-Lee, Y., Robbins, N. & Cowen, L. E. Molecular mechanisms governing antifungal drug resistance. Npj Antimicrobials Resist. 1(1), 5. https:\/\/doi.org\/10.1038\/s44259-023-00007-2 (2023).","journal-title":"Npj Antimicrobials Resist."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88656-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88656-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88656-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:35:39Z","timestamp":1739176539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88656-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88656"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88656-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The method has been approved in terms of compliance with scientific standards and ethical standards of evaluation. Only patient samples routinely collected for diagnosis were used with the approval of Ain Shams University Specialized Hospital, Cairo, Egypt, and no additional samples were collected intentionally for the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"4917"}}